| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 2883287 | The Annals of Thoracic Surgery | 2006 | 6 Pages |
Abstract
Adjuvant chemotherapy consisting of cisplatin and VP-16 after surgery appears promising for the improvement of the prognosis for patients with completely resected LCNECs, and it should be evaluated further in larger multi-institutional trials.
Related Topics
Health Sciences
Medicine and Dentistry
Cardiology and Cardiovascular Medicine
Authors
Akira MD, Kenzo MD, Yasumitsu MD, Yuichi MD, Yasuo MD, Kiyoshi MD, Toshihiko MD, Hideki MD, Yukio MD, Takehiko MD,